Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

ApoE genotype accounts for the vast majority of AD risk and AD pathology.

Raber J, Huang Y, Ashford JW.

Neurobiol Aging. 2004 May-Jun;25(5):641-50. Review.

PMID:
15172743
2.

Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.

Baum L, Chen L, Ng HK, Pang CP.

Microsc Res Tech. 2000 Aug 15;50(4):278-81. Review.

PMID:
10936880
3.

The interaction of amyloid-beta with ApoE.

Carter DB.

Subcell Biochem. 2005;38:255-72. Review.

PMID:
15709483
4.

Apolipoprotein E and Alzheimer's disease: a review of recent studies.

Higgins GA, Large CH, Rupniak HT, Barnes JC.

Pharmacol Biochem Behav. 1997 Apr;56(4):675-85. Review.

PMID:
9130294
5.

Progress toward identification of protease activity involved in proteolysis of apolipoprotein e in human brain.

Marques MA, Owens PA, Crutcher KA.

J Mol Neurosci. 2004;24(1):73-80. Review.

PMID:
15314253
7.

APOE genotype effects on Alzheimer's disease onset and epidemiology.

Ashford JW.

J Mol Neurosci. 2004;23(3):157-65. Review.

PMID:
15181244
8.
9.

Brain-imaging surrogate markers for detection and prevention of age-related memory loss.

Small GW.

J Mol Neurosci. 2002 Aug-Oct;19(1-2):17-21. Review.

PMID:
12212776
10.

Apolipoprotein E4 as a target for developing new therapeutics for Alzheimer's disease.

Refolo LM, Fillit HM.

J Mol Neurosci. 2004;23(3):151-5. Review.

PMID:
15181243
11.

Androgens, apoE, and Alzheimer's disease.

Raber J.

Sci Aging Knowledge Environ. 2004 Mar 17;2004(11):re2. Review.

PMID:
15028864
12.

Pharmacogenomics in Alzheimer's disease.

Cacabelos R.

Methods Mol Biol. 2008;448:213-357. doi: 10.1007/978-1-59745-205-2_10. Review.

PMID:
18370236
13.

ApoE: crossroads between Alzheimer's disease and atherosclerosis.

Stojakovic T, Scharnagl H, März W.

Semin Vasc Med. 2004 Aug;4(3):279-85. Review.

PMID:
15630629
14.

Apolipoprotein E is a prime suspect, not just an accomplice, in Alzheimer's disease.

Crutcher KA.

J Mol Neurosci. 2004;23(3):181-8. Review.

PMID:
15181246
15.

Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.

Capurso C, Solfrizzi V, D'Introno A, Colacicco AM, Capurso SA, Capurso A, Panza F.

Exp Gerontol. 2004 Oct;39(10):1567-73. Review.

PMID:
15501028
16.

Apolipoprotein E gene promoter polymorphisms in Alzheimer's disease.

Bullido MJ, Valdivieso F.

Microsc Res Tech. 2000 Aug 15;50(4):261-7. Review.

PMID:
10936877
17.

Apolipoprotein E and Alzheimer's disease.

Strittmatter WJ, Roses AD.

Annu Rev Neurosci. 1996;19:53-77. Review.

PMID:
8833436
18.

Infiltration of the brain by pathogens causes Alzheimer's disease.

Itzhaki RF, Wozniak MA, Appelt DM, Balin BJ.

Neurobiol Aging. 2004 May-Jun;25(5):619-27. Review.

PMID:
15172740
19.

Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease.

Huang Y, Weisgraber KH, Mucke L, Mahley RW.

J Mol Neurosci. 2004;23(3):189-204. Review.

PMID:
15181247
20.

Morphological, biochemical, and genetic support for an apolipoprotein E effect on microtubular metabolism.

Roses AD, Einstein G, Gilbert J, Goedert M, Han SH, Huang D, Hulette C, Masliah E, Pericak-Vance MA, Saunders AM, Schmechel DE, Strittmatter WJ, Weisgraber KH, Xi PT.

Ann N Y Acad Sci. 1996 Jan 17;777:146-57. Review.

PMID:
8624078

Supplemental Content

Support Center